THNR
NYSE
$25.80
Amplify Weight Loss Drug & Treatment ETF (THNR)
Sector:
Healthcare
Net assets
$4.40M
Inception date
May 20, 2024
Expense ratio
0.59%
Sharpe Ratio
0.61
Price Chart
Valuation
Net assets$4.40M
P/E58.02
Forward P/E20.08
P/S2.55
P/B6.83
Profitability
Profit Margin9.8%
Operating Margin0.9%
Financial Health
Debt-to-Equity95%
Growth & Risk
EPS 5Y CAGR+15.09%
Revenue 5Y CAGR+22.35%
FCF 5Y CAGR+12.85%
Beta (5Y)0.63
Sharpe Ratio0.61